These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1829048)

  • 21. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants.
    Krougliak V; Graham FL
    Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein.
    Doronin K; Toth K; Kuppuswamy M; Ward P; Tollefson AE; Wold WS
    J Virol; 2000 Jul; 74(13):6147-55. PubMed ID: 10846098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector.
    Hersh J; Crystal RG; Bewig B
    Gene Ther; 1995 Mar; 2(2):124-31. PubMed ID: 7719929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intron.
    Mason BB; Davis AR; Bhat BM; Chengalvala M; Lubeck MD; Zandle G; Kostek B; Cholodofsky S; Dheer S; Molnar-Kimber K
    Virology; 1990 Aug; 177(2):452-61. PubMed ID: 2371766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
    Hoffmann D; Wildner O
    BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines.
    Crosby CM; Nehete P; Sastry KJ; Barry MA
    J Virol; 2015 Jan; 89(1):669-75. PubMed ID: 25355873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.
    Fallaux FJ; Bout A; van der Velde I; van den Wollenberg DJ; Hehir KM; Keegan J; Auger C; Cramer SJ; van Ormondt H; van der Eb AJ; Valerio D; Hoeben RC
    Hum Gene Ther; 1998 Sep; 9(13):1909-17. PubMed ID: 9741429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
    Oualikene W; Lamoureux L; Weber JM; Massie B
    Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA immunization with fusion genes encoding different regions of hepatitis C virus E2 fused to the gene for hepatitis B surface antigen elicits immune responses to both HCV and HBV.
    Jin J; Yang JY; Liu J; Kong YY; Wang Y; Li GD
    World J Gastroenterol; 2002 Jun; 8(3):505-10. PubMed ID: 12046080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
    Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
    Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
    Payette PJ; Ma X; Weeratna RD; McCluskie MJ; Shapiro M; Engle RE; Davis HL; Purcell RH
    Intervirology; 2006; 49(3):144-51. PubMed ID: 16428890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The protection of chimpanzees against hepatitis B viral infection using a recombinant yeast-derived hepatitis B surface antigen.
    Schellekens H; de Reus A; Peetermans JH; van Eerd PA
    Postgrad Med J; 1987; 63 Suppl 2():93-6. PubMed ID: 3317363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.
    Zhai Y; Yang JC; Kawakami Y; Spiess P; Wadsworth SC; Cardoza LM; Couture LA; Smith AE; Rosenberg SA
    J Immunol; 1996 Jan; 156(2):700-10. PubMed ID: 8543823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replication-defective adenovirus type 5 as an in vitro and in vivo gene transfer vector in chickens.
    Adam M; Oualikene W; Le Cocq H; Guittet M; Eloit M
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3153-7. PubMed ID: 8847523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermittent, repetitive corticosteroid-induced upregulation of platelet levels after adenovirus-mediated transfer to the liver of a chimeric glucocorticoid-responsive promoter controlling the thrombopoietin cDNA.
    Narumi K; Suzuki M; Song W; Moore MA; Crystal RG
    Blood; 1998 Aug; 92(3):822-33. PubMed ID: 9680350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart muscle-specific gene expression using replication defective recombinant adenovirus.
    Rothmann T; Katus HA; Hartong R; Perricaudet M; Franz WM
    Gene Ther; 1996 Oct; 3(10):919-26. PubMed ID: 8908506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel method for gene delivery and expression in esophageal epithelium with fibrin glues containing replication-deficient adenovirus vector.
    Teraishi F; Umeoka T; Saito T; Tsukagoshi T; Tanaka N; Fujiwara T
    Surg Endosc; 2003 Nov; 17(11):1845-8. PubMed ID: 14959729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication.
    Bernt K; Liang M; Ye X; Ni S; Li ZY; Ye SL; Hu F; Lieber A
    J Virol; 2002 Nov; 76(21):10994-1002. PubMed ID: 12368342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live recombinant vaccinia virus protects chimpanzees against hepatitis B.
    Moss B; Smith GL; Gerin JL; Purcell RH
    Nature; 1984 Sep 6-11; 311(5981):67-9. PubMed ID: 6472464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction of adenoviral and retroviral vectors coexpressing the genes encoding the hepatitis B surface antigen and B7-1 protein.
    He XS; Rivkina M; Robinson WS
    Gene; 1996 Oct; 175(1-2):121-5. PubMed ID: 8917087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.